Tata India Pharma & HealthCare Fund Regular-IDCW Payout

style
sticky-block

Equity, Sectoral-Pharma, Principal at very high risk

1 Year Return 5.13% at 08 Jun 2026 01:07 PM

mf-nav

Tata India Pharma & HealthCare Fund Regular-IDCW Payout: Mutual Fund Overview

Tata India Pharma & HealthCare Fund Regular-IDCW Payout is an Sectoral-Pharma mutual fund with over 10.44 years of performance history. The scheme manages an AUM of ₹1325.18 Cr and has a NAV of ₹29.8866. It is rated '2' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 5.13%.

style
pb-0

Fund Details

NAV 29.8866

Sub-Type Sectoral-Pharma

Rating 2

Min. SIP Amount ₹100.0

Fund Age(Year) 10.44

Fund Size(in Crores) 1325.18

Fund Performance

1 Month 1.51%

3 Month 4.34%

6 Month 1.29%

1 Year 5.13%

3 Year 21.75%

5 Year 13.21%

Know This Fund

As on 08 Jun 2026

Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.

Equity (99.6%) Market Cap Large Cap 26.6 Mid Cap 34.93 Small Cap 38.07 Top Sectors Healthcare 93.74 Chemicals 5.19 Insurance 0.67 Top Holding Abbott India 5.37 Ajanta Pharma 1.9 Alkem Laboratories 2.49 Apollo Hospitals Enterprise 4.06 Aurobindo Pharma 0.7 Bayer CropScience 3.34 Cipla 5.07 CORONA Remedies 0.77 Divi's Laboratories 5.92 Dr. Agarwal's Health Care 0.07 Dr. Lal Pathlabs 2.6 Dr. Reddy's Laboratories 3.73 FDC 1.94 Fortis Healthcare 3.55 Glaxosmithkline Pharma 2.44 Global Health 2.16 HDFC Life Insurance 0.67 Healthcare Global Enterprises 5.45 Ipca Laboratories 0 JB Chemicals 2.21 Jubilant Pharmova 0.36 Lupin 2.94 Mankind Pharma 3.73 Max Healthcare Institute 5.17 Metropolis Healthcare 3.07 Neuland Laboratories 2.41 PI Industries 0.7 Procter & Gamble Health 1.55 Rainbow Children's 4.23 Sai Life Sciences 2.63 Sanofi India 1.68 Sumitomo Chemical India 0.43 Sun Pharmaceutical Industries 9.87 Syngene International 2.94 Tata Chemicals 0.72 Torrent Pharmaceuticals 1.01 Vijaya Diagnostic Centre 1.72

Debt & Others (0.4%) Sector Allocation Repo 0.22 Cash/Net Current Assets 0.18 Debt Credit Ratings Debt Category Others 0.4

Comparison with same funds

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 3.39% Ret 1Y 10.62% Ret 3Y 23.31% Ret 5Y 12.6%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M 3.87% Ret 1Y 9.17% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 3.46% Ret 1Y 8.34% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-Growth Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Reinvestment Ret 1M 2.37% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 3.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Charges & Taxes Expense Ratio

Returns are taxed as per your Income Tax Slab.

Expense Ratio (Inclusive of GST): 2.35%

Exit Load 0.25%

Stamp Duty 0.005%

Fund Management

The various expenses, charges and taxes associated with your Mutual Fund

Rajat Srivastava

Education Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad

Experience Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services

Meeta Shetty

Education Ms. Shetty is Bachelor in Economics and CFA Charterholder

Experience Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.

Riskometer

Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.

Principal at very high risk

AMC and Fund details

Rank (total sets) 30

Date of Incorporation 2015-12-28

Total AUM 227426.64

The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.

Latest News

news-by-category

VIEW MORE NEWS

style
button-arrow,btn-center

Take Your Next Step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center

Tata India Pharma & HealthCare Fund Regular-IDCW Payout FAQs

How to invest in Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

Investing in Tata India Pharma & HealthCare Fund Regular-IDCW Payout through Motilal Oswal is simple and completely online. You just need to follow the step-by-step process below to get started in a few minutes.

What is the expense ratio of Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

The term expense ratio for Tata India Pharma & HealthCare Fund Regular-IDCW Payout or any other mutual fund is the annual fee charged by the fund house for managing your investment scheme. The expense ratio of Tata India Pharma & HealthCare Fund Regular-IDCW Payout is 2.35% as of 08 Jun 2026.

What is the NAV of Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

The NAV of Tata India Pharma & HealthCare Fund Regular-IDCW Payout is ₹29.8866 as of 08 Jun 2026.

What is the AUM of Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

The AUM (Assets Under Management) of Tata India Pharma & HealthCare Fund Regular-IDCW Payout is the total value of assets managed by the fund at a given time, which is updated regularly. The AUM of Tata India Pharma & HealthCare Fund Regular-IDCW Payout is ₹1325.18 Cr as of 08 Jun 2026.

What is the PE and PB ratio of Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

The PE ratio of Tata India Pharma & HealthCare Fund Regular-IDCW Payout shows how much investors are paying for the fund's underlying earnings, while the PB ratio indicates how the fund's holdings are valued compared to their book value.

Can I invest in SIP and Lump Sum in Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

Yes, you can invest in Tata India Pharma & HealthCare Fund Regular-IDCW Payout through both SIP (Systematic Investment Plan) and lump sum options, depending on your investment preference and financial goals.

What is the return of Tata India Pharma & HealthCare Fund Regular-IDCW Payout in the last 5 years?

The return of Tata India Pharma & HealthCare Fund Regular-IDCW Payout in the last 5 years is 13.21%.

What is the minimum SIP investment required in Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

The minimum SIP investment in Tata India Pharma & HealthCare Fund Regular-IDCW Payout depends on the fund's scheme rules and usually starts at a small amount. For Tata India Pharma & HealthCare Fund Regular-IDCW Payout, the minimum SIP amount is ₹100.0.

What is the current NAV of Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

The NAV of Tata India Pharma & HealthCare Fund Regular-IDCW Payout, as of 08 Jun 2026, is ₹29.8866.

Who manages the Tata India Pharma & HealthCare Fund Regular-IDCW Payout?

The fund managers responsible for Tata India Pharma & HealthCare Fund Regular-IDCW Payout are: